{
    "name": "Confidentiality of information; disclosure of information",
    "number": "104",
    "text": "\u00a7329-104\u00a0 Confidentiality of information; disclosure of information. \u00a0(a)\u00a0 The information collected under this part shall not be available to the public or used for any commercial purpose.\u00a0 Ownership of all data collected shall reside with the State.\n\u00a0\u00a0\u00a0\u00a0 (b)\u00a0 Responsibility for limiting access to information in the system is vested in the administrator.\u00a0 Access to the information collected at the central repository pursuant to this part shall be confidential, and access to the information shall be limited to personnel of the designated state agency.\n\u00a0\u00a0\u00a0\u00a0 (c)\u00a0 This section shall not prevent the disclosure, at the discretion of the administrator, of investigative information to:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Law enforcement officers, investigative agents of federal, state, or county law enforcement or regulatory agencies, United States attorneys, county prosecuting attorneys, or the attorney general; provided that the administrator has reasonable grounds to believe that the disclosure of any information collected under this part is in furtherance of an ongoing criminal or regulatory investigation or prosecution;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Registrants authorized under chapters 448, 453, and 463E who are registered to administer, prescribe, or dispense controlled substances and their practitioner delegate; provided that the information disclosed relates only to the registrant's own patient;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Pharmacists or pharmacist delegates, employed by a pharmacy registered under section 329-32, who request prescription information about a customer relating to a violation or possible violation of this chapter; \n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Other state-authorized governmental prescription-monitoring programs;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 The chief medical examiner or licensed physician designee who requests information and certifies the request is for the purpose of investigating the death of an individual;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Qualified personnel for the purpose of bona fide research or education; provided that data elements that would reasonably identify a specific recipient, prescriber, or dispenser shall be deleted or redacted from the information prior to disclosure; provided further that release of the information may be made only pursuant to a written agreement between qualified personnel and the administrator in order to ensure compliance with this subsection; and\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 Other entities or individuals authorized by the administrator to assist the program with projects that enhance the electronic prescription accountability system.\nInformation disclosed to a registrant, pharmacist, or authorized government agency under this section shall be transmitted by a secure means determined by the designated agency.\n\u00a0\u00a0\u00a0\u00a0 (d)\u00a0 No person shall knowingly disclose or attempt to disclose, or use or attempt to use, information in the system in violation of this section.\u00a0 Any person who violates this section is guilty of a class C felony.\n\u00a0\u00a0\u00a0\u00a0 (e)\u00a0 The designated state agency shall purge or cause to be purged from the central repository system, no later than five years after the date a patient's prescription data are made available to the designated state agency, the identification number of the patient, unless the information is part of an active investigation. [L 1996, c 268, pt of \u00a72; am L 1999, c 145, \u00a71; am L 2001, c 162, \u00a71; am L 2006, c 69, \u00a76; am L 2009, c 11, \u00a742; am L 2010, c 123, \u00a78; am L 2016, c 218, \u00a717]"
}